2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
FDA Comment Number : | EC2656 | |||||||||||||||||||||||
Submitter : | Mr. Daniel Gibbons | Date & Time: | 12/06/2006 09:12:38 | |||||||||||||||||||||
Organization : | Mr. Daniel Gibbons | |||||||||||||||||||||||
Category : | Academia | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
Please do not treat human bodies as raw material for experimentation by using human embryos, living or dead, for the development of vaccines, etc. More ethical means are available -- please use them! | ||||||||||||||||||||||||